These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28217652)

  • 21. Prediction of benignity or malignancy of a lesion using BI-RADS.
    Masroor I
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):686-8. PubMed ID: 16300702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
    Liberman L; Abramson AF; Squires FB; Glassman JR; Morris EA; Dershaw DD
    AJR Am J Roentgenol; 1998 Jul; 171(1):35-40. PubMed ID: 9648759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result?
    Onishi N; Kataoka M; Kanao S; Kawai M; Iima M; Ohashi A; Toi M; Togashi K
    Breast Cancer; 2017 Jan; 24(1):69-78. PubMed ID: 26832858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Value of Shear Wave Elastography Added to Targeted Ultrasound (Second-Look Ultrasound) in the Evaluation of Breast Lesions Suspicious of Malignancy Detected on Magnetic Resonance Imaging.
    Au FW; Ghai S; Lu FI; Lu H
    J Ultrasound Med; 2019 Sep; 38(9):2395-2406. PubMed ID: 30666681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies.
    Abramovici G; Mainiero MB
    Radiology; 2011 Apr; 259(1):85-91. PubMed ID: 21285337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
    Yao MM; Joe BN; Sickles EA; Lee CS
    Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of breast core needle biopsy (CNB) findings with ultrasound BI-RADS subtyping.
    Taghipour Zahir S; Aminpour S; Jafari-Nedooshan J; Rahmani K; SafiDahaj F
    Pol Przegl Chir; 2022 May; 95(2):1-6. PubMed ID: 36805305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interobserver variability of ultrasound elastography and the ultrasound BI-RADS lexicon of breast lesions.
    Park CS; Kim SH; Jung NY; Choi JJ; Kang BJ; Jung HS
    Breast Cancer; 2015 Mar; 22(2):153-60. PubMed ID: 23584596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI in the Assessment of BI-RADS® 4 lesions.
    Leithner D; Wengert G; Helbich T; Morris E; Pinker K
    Top Magn Reson Imaging; 2017 Oct; 26(5):191-199. PubMed ID: 28961568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
    Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
    Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
    Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast Imaging Reporting and Data System Category 3 Lesions Detected on Whole-Breast Screening Ultrasound.
    Nam SY; Ko EY; Han BK; Shin JH; Ko ES; Hahn SY
    J Breast Cancer; 2016 Sep; 19(3):301-307. PubMed ID: 27721880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer-aided classification of BI-RADS category 3 breast lesions.
    Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
    Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.
    Lee SH; Kim SM; Jang M; Yun BL; Kang E; Kim SW; Park SY; Ahn HS; Chang JH; Yoo Y; Song TK; Moon WK
    Ultraschall Med; 2015 Apr; 36(2):140-8. PubMed ID: 25750138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
    Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
    Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing?
    Shimauchi A; Machida Y; Maeda I; Fukuma E; Hoshi K; Tozaki M
    Acad Radiol; 2018 Mar; 25(3):288-296. PubMed ID: 29191685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.